Clinical Trial Update: Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the BEP chemotherapy regimen (bleomycin, etoposide, cisplatin) for metastatic testicular germ cell tumor has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Testicular Germ Cell Tumor

Drugs mentioned

• Bleomycin (bleomycin)
• CISPLATIN (cisplatin)
• Etoposide (Etoposide)

Snippet

Sponsor: Queen Mary University of London | Conditions: Drug/Agent Toxicity by Tissue/Organ, Testicular Germ Cell Tumor | Phase 3 | Status: COMPLETED